GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,411,000 | -35.0% | 170,145 | -34.2% | 0.07% | -35.0% |
| Q4 2021 | $11,397,000 | +101.9% | 258,449 | +74.9% | 0.10% | +77.6% |
| Q3 2021 | $5,645,000 | +31.2% | 147,745 | +40.1% | 0.06% | 0.0% |
| Q2 2020 | $4,302,000 | +318.5% | 105,488 | +289.0% | 0.06% | -10.8% |
| Q1 2020 | $1,028,000 | +256.9% | 27,118 | +293.0% | 0.06% | +550.0% |
| Q1 2019 | $288,000 | -41.2% | 6,900 | -43.4% | 0.01% | -54.5% |
| Q3 2018 | $490,000 | -69.7% | 12,200 | -73.2% | 0.02% | -83.3% |
| Q4 2017 | $1,617,000 | +372.8% | 45,577 | +474.9% | 0.13% | +277.1% |
| Q2 2017 | $342,000 | -42.9% | 7,928 | -44.1% | 0.04% | -41.7% |
| Q1 2017 | $599,000 | +103.7% | 14,187 | +108.1% | 0.06% | +20.0% |
| Q3 2016 | $294,000 | +8.9% | 6,817 | +9.5% | 0.05% | -16.7% |
| Q2 2016 | $270,000 | – | 6,225 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |